Delaware Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of March 1)
  This week's View covers articles about the rates of antiarrhythmic drug and catheter ablation use for the management of paroxysmal atrial fibrillation (AF) in terms of race/ethnicity and socioeconomic status, whether socioeconomic factors and sex differences play a role in changing trends in AF incidence and mortality, and the relationship between the renin-angiotensin-aldosterone system and […]
• Analysis of Inclisiran Trials on Hypercholesterolemia or Atherosclerosis
  Is inclisiran, a double-stranded small interfering RNA that suppresses proprotein convertase subtilisin–kexin type 9 (PCSK9) translation in the liver, effective for low-density lipoprotein cholesterol (LDL-C)?
• Medication Safety After Hospitalization in Patients Prescribed High-Risk Medications
  Does a single home visit by a clinical pharmacist shortly after hospital discharge (which includes written educational materials) impact the 45-day incidence rate of adverse drug-related events and clinically important medication errors?
• Outcomes 2 Years After TAVR in Patients at Low Surgical Risk
  What are the clinical and echocardiographic outcomes between 1 and 2 years in the PARTNER 3 (Placement of Aortic Transcatheter Valves) trial?
• Cerebral Embolic Protection for TAVR: TVT Registry Results
  What is the relationship between embolic protection device (EPD) use during transcatheter aortic valve replacement (TAVR) and clinical outcomes?